{"id":11752,"date":"2021-12-10T12:48:32","date_gmt":"2021-12-10T17:48:32","guid":{"rendered":"http:\/\/sites.bu.edu\/urbanarch\/?page_id=11752"},"modified":"2022-03-25T12:50:06","modified_gmt":"2022-03-25T16:50:06","slug":"newsletter-4","status":"publish","type":"page","link":"https:\/\/sites.bu.edu\/urbanarch\/newsletter-4\/","title":{"rendered":"Newsletter"},"content":{"rendered":"<h3 style=\"text-align: right;\"><span>Volume 8, Issue 4<\/span><\/h3>\n<h3 style=\"text-align: right;\"><span>October \u2013\u00a0December 2021<\/span><\/h3>\n<hr \/>\n<h3><strong>Check out the current issue of <em>URBAN ARCH News<\/em>, the quarterly newsletter bringing you news on the latest URBAN ARCH and related research.<\/strong><\/h3>\n<hr \/>\n<h3 style=\"text-align: center;\"><span style=\"color: #0000ff;\"><a href=\"https:\/\/sites.bu.edu\/urbanarch\/microbiome-metabolites-and-alcohol-in-hiv-to-reduce-cvd-meta-hiv-cvd-program-project-grant\/\" style=\"color: #0000ff;\">Introducing the New Microbiome, Metabolites, and Alcohol in HIV to reduce CVD (META HIV CVD) Program Project Grant\u00a0<\/a><\/span><a href=\"https:\/\/sites.bu.edu\/urbanarch\/microbiome-metabolites-and-alcohol-in-hiv-to-reduce-cvd-meta-hiv-cvd-program-project-grant\/\"><img loading=\"lazy\" src=\"\/urbanarch\/files\/2021\/12\/META-HIV-CVD-Microbiome-Metabolites-and-Alcohol-in-HIV-to-reduce-CVD.png\" alt=\"\" width=\"596\" height=\"212\" class=\"aligncenter wp-image-11749\" \/><\/a><\/h3>\n<p style=\"text-align: center;\"><strong><span>In this edition of the URBAN ARCH Newsletter we highlight the new NIAAA-funded META HIV CVD P01.<\/span><\/strong><a href=\"https:\/\/sites.bu.edu\/urbanarch\/integrated-metagenomic-and-metabolomic-core-information-for-urban-arch-newsletter\/\"><\/a><\/p>\n<div _mce_style=\"font-family: Arial, Helvetica, sans-serif; font-size: 10pt;\">\n<hr \/>\n<div _mce_style=\"font-family: Arial, Helvetica, sans-serif; font-size: 10pt;\">\n<h4>Learn about the two META HIV CVD research components:<\/h4>\n<ul>\n<li><strong>Project 1:<\/strong>\u00a0<span style=\"color: #0000ff;\"><a href=\"https:\/\/sites.bu.edu\/urbanarch\/project-1-interview-for-urban-arch-newsletter\/\" style=\"color: #0000ff;\"><i>Microbiome, mETabolites, and Alcohol in HIV to reduce CVD Randomized Controlled Trial (META HIV CVD RCT)<\/i><\/a><\/span>\n<ul>\n<li><span>Including an\u00a0interview\u00a0with&#8230; <strong>Elena Blokhina<\/strong><\/span>\n<ul>\n<li><span><span>We interview Elena Blokhina,<\/span><\/span> MD, PhD, Co-Investigator, Global Health Institute\/First St. Petersburg Pavlov State Medical University.<strong><br \/>\n<\/strong><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li><strong>Project 2<\/strong>:\u00a0<span style=\"color: #0000ff;\"><a href=\"https:\/\/sites.bu.edu\/urbanarch\/project-2-interview-for-urban-arch-newsletter-q4-2021\/\" style=\"color: #0000ff;\"><i>Microbiome, mETabolites, and Alcohol in HIV to reduce CVD Cohort (META HIV CVD Cohort)<\/i><\/a><\/span>\n<ul>\n<li>Including an interview with&#8230; <strong>Kaku So-Armah<\/strong> and <strong>Samuel Mensah<\/strong>\n<ul>\n<li>We interview Kaku So-Armah, PhD, Assistant Professor of Medicine, Boston University School of Medicine, and Samuel Mensah, MD, MPH, Project Coordinator at Boston Medical Center.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<hr \/>\n<h4 _mce_style=\"font-family: Arial, Helvetica, sans-serif; font-size: 10pt;\"><strong>Learn about the two META HIV CVD cores:<\/strong><\/h4>\n<ul>\n<li _mce_style=\"font-family: Arial, Helvetica, sans-serif; font-size: 10pt;\"><span style=\"color: #0000ff;\"><a href=\"https:\/\/sites.bu.edu\/urbanarch\/meta-hiv-cvd-admin-core\/\" style=\"color: #0000ff;\">Click here to read about the Administrative Core and meet the team!<\/a><\/span><\/li>\n<li style=\"text-align: left;\"><span style=\"color: #0000ff;\"><a href=\"https:\/\/sites.bu.edu\/urbanarch\/integrated-metagenomic-and-metabolomic-core-information-for-urban-arch-newsletter\/\" style=\"color: #0000ff;\">Click here to read about the\u00a0Integrated Metagenomics and\u00a0Metabolomics Core (IMMC)!<\/a><\/span><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<hr \/>\n<h4><a href=\"https:\/\/sites.bu.edu\/urbanarch\/spotlight-on-emily-and-grace\/\"><strong><span style=\"color: #0000ff;\">Special Spotlight on&#8230; Emily Smith and Grace Wallace<\/span><\/strong><\/a><a href=\"\/urbanarch\/files\/2021\/12\/Henderson_Grace-scaled.jpg\"><\/a><\/h4>\n<p><a href=\"\/urbanarch\/files\/2021\/12\/Emily-and-Grace-2.png\"><img loading=\"lazy\" src=\"\/urbanarch\/files\/2021\/12\/Emily-and-Grace-2-636x442.png\" alt=\"\" width=\"248\" height=\"172\" class=\"wp-image-11888 alignleft\" srcset=\"https:\/\/sites.bu.edu\/urbanarch\/files\/2021\/12\/Emily-and-Grace-2-636x442.png 636w, https:\/\/sites.bu.edu\/urbanarch\/files\/2021\/12\/Emily-and-Grace-2-1024x712.png 1024w, https:\/\/sites.bu.edu\/urbanarch\/files\/2021\/12\/Emily-and-Grace-2-768x534.png 768w, https:\/\/sites.bu.edu\/urbanarch\/files\/2021\/12\/Emily-and-Grace-2.png 1036w\" sizes=\"(max-width: 248px) 100vw, 248px\" \/><\/a><\/p>\n<p><strong>Emily Smith<\/strong> is a Senior Program Manager at Vanderbilt University Medical Center.<\/p>\n<p><strong>Grace Wallace<\/strong> is a Project Manager at Vanderbilt University Medical Center.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p><span style=\"color: #000000;\"><a href=\"https:\/\/sites.bu.edu\/urbanarch\/publications\/\" style=\"color: #000000;\"><strong>New URBAN ARCH Publications<\/strong><\/a><\/span><\/p>\n<ul>\n<li><span>Rossi SL, Sereda Y, Luoma J, Pavlov N, Toussova O, Vasileva J, Abramova K, Bendiks S, Kiriazova T, Vetrova M, Blokhina E, Krupitsky E, Lioznov D, Lodi S, Lunze K. (2021).\u00a0<a href=\"https:\/\/doi.org\/10.1016\/j.conctc.2021.100861\"><span style=\"color: #0000ff;\">Addressing intersectional stigma as a care barrier for HIV-positive people who inject drugs: Design of an RCT in St. Petersburg, Russia<\/span><\/a>.\u00a0<em>Contemp\u00a0Clin\u00a0Trials Commun.<\/em><em>\u00a0<\/em>2021;24:100861. PMCID: PMC8636824<\/span><\/li>\n<\/ul>\n<hr \/>\n<p><span style=\"color: #000000;\"><a href=\"https:\/\/sites.bu.edu\/urbanarch\/resources\/upcoming-events-and-conferences\/\" style=\"color: #000000;\"><strong>Events and Conferences<\/strong><\/a><\/span><\/p>\n<ul>\n<li><span style=\"color: #000000;\"><span style=\"color: #0000ff;\"><a href=\"https:\/\/www.croiconference.org\/\" rel=\"noopener noreferrer\" target=\"_blank\" style=\"color: #0000ff;\">Conference on Retroviruses and Opportunistic Infections (CROI)<\/a>:<\/span> February 13 \u2013 16, 2022; Denver, Colorado, USA\/Virtually. Late Breaking Abstract Deadline: January 5, 2022.<\/span><\/li>\n<li><span style=\"color: #000000;\"><a href=\"https:\/\/cpdd.org\/meetings\/future-meetings\/\" style=\"color: #000000;\"><span style=\"color: #0000ff;\">College on Problems of Drug Dependence (CPDD)<\/span><\/a>:\u00a0June 11 \u2013 15, 2022; Minneapolis, Minnesota, USA. Workshops\/symposia deadline:\u00a0November 3, 2021. Abstract Submissions deadline: January 4, 2022.<\/span><\/li>\n<li><span style=\"color: #000000;\"><span style=\"color: #0000ff;\"><a href=\"http:\/\/www.rsoa.org\/future-meetings\" style=\"color: #0000ff;\">Research Society on Alcoholism (RSA)<\/a><\/span><a href=\"https:\/\/www.xcdsystem.com\/rsoa\/index.cfm?ID=5LxjLrk&amp;CFID=38141318&amp;CFTOKEN=e8d45c7444e3ab4f-FD34C4CD-E81C-892B-215F9DC9170C677D\" style=\"color: #000000;\">:<\/a>\u00a0June 25 \u2013 29, 2022; Orlando, Florida, USA.<\/span><\/li>\n<\/ul>\n<p><span style=\"color: #000000;\">Click\u00a0<span style=\"color: #0000ff;\"><a href=\"https:\/\/sites.bu.edu\/urbanarch\/resources\/upcoming-events-and-conferences\/\" style=\"color: #0000ff;\">here<\/a>\u00a0<\/span>for more events and conferences.<\/span><\/p>\n<p><a href=\"\/urbanarch\/files\/2021\/12\/AdobeStock_290490056-scaled.jpeg\"><img loading=\"lazy\" src=\"\/urbanarch\/files\/2021\/12\/AdobeStock_290490056-636x199.jpeg\" alt=\"\" width=\"839\" height=\"263\" class=\"wp-image-11838 aligncenter\" srcset=\"https:\/\/sites.bu.edu\/urbanarch\/files\/2021\/12\/AdobeStock_290490056-636x199.jpeg 636w, https:\/\/sites.bu.edu\/urbanarch\/files\/2021\/12\/AdobeStock_290490056-1024x321.jpeg 1024w, https:\/\/sites.bu.edu\/urbanarch\/files\/2021\/12\/AdobeStock_290490056-768x240.jpeg 768w, https:\/\/sites.bu.edu\/urbanarch\/files\/2021\/12\/AdobeStock_290490056-1536x481.jpeg 1536w, https:\/\/sites.bu.edu\/urbanarch\/files\/2021\/12\/AdobeStock_290490056-2048x641.jpeg 2048w\" sizes=\"(max-width: 839px) 100vw, 839px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Volume 8, Issue 4 October \u2013\u00a0December 2021 Check out the current issue of URBAN ARCH News, the quarterly newsletter bringing you news on the latest URBAN ARCH and related research. Introducing the New Microbiome, Metabolites, and Alcohol in HIV to reduce CVD (META HIV CVD) Program Project Grant\u00a0 In this edition of the URBAN ARCH [&hellip;]<\/p>\n","protected":false},"author":16853,"featured_media":0,"parent":0,"menu_order":212,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/sites.bu.edu\/urbanarch\/wp-json\/wp\/v2\/pages\/11752"}],"collection":[{"href":"https:\/\/sites.bu.edu\/urbanarch\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.bu.edu\/urbanarch\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/urbanarch\/wp-json\/wp\/v2\/users\/16853"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/urbanarch\/wp-json\/wp\/v2\/comments?post=11752"}],"version-history":[{"count":36,"href":"https:\/\/sites.bu.edu\/urbanarch\/wp-json\/wp\/v2\/pages\/11752\/revisions"}],"predecessor-version":[{"id":11942,"href":"https:\/\/sites.bu.edu\/urbanarch\/wp-json\/wp\/v2\/pages\/11752\/revisions\/11942"}],"wp:attachment":[{"href":"https:\/\/sites.bu.edu\/urbanarch\/wp-json\/wp\/v2\/media?parent=11752"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}